|[February 19, 2014]
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Zale Corporation over the Proposed Sale of the Company to Signet Jewelers
NEW YORK --(Business Wire)--
E. Monteverde, a partner at Faruqi
& Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of Zale
Corporation ("Zale" or the "Company") (NYSE:ZLC) for potential breaches
of fiduciary duties in connection with the sale of the Company to Signet
for approximately $690 million. The Company's stockholders will receive
$21 per share for each share of Zale common stock they own.
Cick here for more information: www.faruqilaw.com/ZLC.
There is no cost or obligation to you.
The investigation focuses on whether Zale' Board of Directors breached
their fiduciary duties to the Company's stockholders by failing to
conduct a fair sales process and whether and by how much this proposed
transaction undervalues the Company to the detriment of Zale's
& Faruqi, LLP is a national law firm which represents investors
and individuals in class action litigation. The firm is focused on
providing exemplary legal services in complex litigation in the areas of
securities, shareholder, antitrust and consumer litigation, throughout
all phases of litigation. The firm has an experienced trial team which
has achieved significant victories on behalf of the firm's clients. To
keep track of the latest securities litigation news, follow us on
Twitter (News - Alert) at www.twitter.com/MergerActivity
or on Facebook (News - Alert) at www.facebook.com/FaruqiLaw.
If you own common stock in Zale and wish to obtain additional
information and protect your investments free of charge, please visit us
or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2014 Faruqi & Faruqi, LLP. The law firm
responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We are happy to discuss your particular case.
[ Back To TMCnet.com's Homepage ]